Why Cancer Patients Still Die From Infections We Can't Diagnose - Karius
In this episode of Diagnosing Dx, David Filby is joined by Alec Ford, Chief Executive Officer at Karius.
Alec brings decades of leadership experience across therapeutics, vaccines, and genomics. In this conversation, we explore how Karius is bringing genomics into infectious disease and why the company has focused so sharply on immunocompromised patients.
The scale of the unmet need is staggering. Alec explains that 52% of cancer deaths in the US are due to infection rather than the underlying malignancy, rising to more than 60% in hematologic malignancies. He also shares that there are…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.